Tianjin Taihe Pharmaceutical Co., Ltd. is a private pharmaceutical company established in 1994, located in Tianjin, China. The company focuses on the development, manufacturing, and marketing of pharmaceutical products. One of its notable drug candidates is Boanmycin Hydrochloride, which is indicated for the treatment of head and neck neoplasms. The drug received approval in China on June 24, 2004. Taihe Pharmaceutical specializes in various therapeutic areas, including immune system diseases, digestive system disorders, and hemic and lymphatic diseases. The company has been involved in clinical trials and has multiple deals associated with its drug development efforts​